Gavreto
Pralsetinib · Rigel Pharmaceuticals, Inc.
CANCER MEDICINE · PRESCRIPTION ONLY (USA)Gavreto ingredients
| Active ingredient | Strength |
|---|---|
| Pralsetinib | 100 mg/1 |
What Gavreto is used for
Gavreto is a cancer medicine (kinase inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Gavreto
- Generic name
- Pralsetinib
- Made by
- Rigel Pharmaceuticals, Inc.
- Forms
- Capsule
- Given
- Oral
- Drug class
- Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA213721
- On the US market since
- 2024
Official information
- Gavreto prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Pralsetinib)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Gavreto?
Gavreto (Pralsetinib) is a cancer medicine made by Rigel Pharmaceuticals, Inc., approved by the US FDA.
What are the ingredients of Gavreto?
Gavreto contains Pralsetinib (100 mg/1).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA